tecovirimat will enhance the stage or influence of diazepam by affecting hepatic enzyme CYP2C19 metabolism. Use Caution/Watch. Tecovirimat is a weak inhibitor of CYP2C8 and CYP2C19. Monitor for adverse outcomes if coadministered with delicate substrates of those enzymes.Prescribers are strongly encouraged to acquire all acceptable methods to make c